🇺🇸 FDA
Patent

US 11976309

Fusion proteins and methods for site-directed genome editing

granted A61KA61K38/00

Quick answer

US patent 11976309 (Fusion proteins and methods for site-directed genome editing) held by The Regents of the University of California expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00